<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03800563</url>
  </required_header>
  <id_info>
    <org_study_id>ALM-Lipo-002</org_study_id>
    <nct_id>NCT03800563</nct_id>
  </id_info>
  <brief_title>Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System</brief_title>
  <official_title>The Safety and Efficacy of Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alma Lasers</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alma Lasers</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multi-center, prospective, open-label, single arm study. The study aims to evaluate the&#xD;
      safety and efficacy of Laser Assisted Liposuction procedure performed with the LipoLife&#xD;
      system. The study will include twenty (20) eligible subjects, that are willing to undergo&#xD;
      abdominal or outer thighs laser-assisted liposuction. Five to twenty (5-20) subjects out of&#xD;
      this study group should also be eligible for facial fat grafting. Follow up visits to&#xD;
      evaluate study endpoints will take place at 1, 3 and 6 months after the surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 6, 2018</start_date>
  <completion_date type="Actual">May 20, 2020</completion_date>
  <primary_completion_date type="Actual">September 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blinded comparison of before and after photographs</measure>
    <time_frame>3 months</time_frame>
    <description>Improvement in aesthetic appearance as determined by blinded comparison of before and after photographs.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Laser Assisted Liposuction</condition>
  <arm_group>
    <arm_group_label>Laser assisted liposuction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laser Assisted Liposuction with the LipoLife system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LipoLife system</intervention_name>
    <description>Abdominal/ Outer thighs Laser Assisted Liposuction. Five to twenty subjects out of the study group will also undergo facial fat grafting.</description>
    <arm_group_label>Laser assisted liposuction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects with excessive fat in the lower abdomen or subjects with excessive fat in the&#xD;
             outer thighs that are willing to undergo laser-assisted liposuction&#xD;
&#xD;
          -  Estimated fat harvesting of 1-3 liters&#xD;
&#xD;
          -  Subjects (5-20) eligible for facial fat grafting of at least 5 cc for each cheek&#xD;
&#xD;
          -  Between 18 and 70 years of age&#xD;
&#xD;
          -  Provided written Informed Consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body Mass Index (BMI) &gt;35&#xD;
&#xD;
          -  Sever skin laxity&#xD;
&#xD;
          -  Positive pregnancy test&#xD;
&#xD;
          -  Current smoker&#xD;
&#xD;
          -  Presence of known malignancy&#xD;
&#xD;
          -  Active infection in the treatment area&#xD;
&#xD;
          -  History of autoimmune disorder (e.g., Systemic Lupus Erythematosus [SLE])&#xD;
&#xD;
          -  History of connective, metabolic or atrophic skin disease&#xD;
&#xD;
          -  History of keloid scarring&#xD;
&#xD;
          -  Chronic use (&gt;7 consecutive days) of anticoagulants (such as aspirin) or NSAIDs within&#xD;
             15 days prior to enrollment&#xD;
&#xD;
          -  Subjects with immune system diseases&#xD;
&#xD;
          -  Subject unable to follow post-treatment instructions&#xD;
&#xD;
          -  Any other reason that in the opinion of the investigator, prevents the subject from&#xD;
             participating in the study or compromise the subject safety.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason N. Pozner, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanctuary Plastic Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lior Heller, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yitzhak Shamir Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanctuary Plastic Surgery</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yitzhak Shamir Medical Center</name>
      <address>
        <city>Be'er Ya'aqov</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>January 9, 2019</study_first_submitted>
  <study_first_submitted_qc>January 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 11, 2019</study_first_posted>
  <last_update_submitted>September 23, 2020</last_update_submitted>
  <last_update_submitted_qc>September 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

